Stay updated on Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial page.

Latest updates to the Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial for BI 655130 in patients with atopic dermatitis, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference18%
- Check39 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-24.SummaryDifference0.4%
- Check82 days agoChange DetectedThe webpage has been updated to include new clinical study data sharing policies and timelines, specifically for studies sponsored by Boehringer Ingelheim, while removing outdated information regarding previous updates and access procedures.SummaryDifference13%
- Check96 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check103 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of BI 655130 in Atopic Eczema: Clinical Trial page.